Stephan Moll, MD writes…
If you are considering to start therapy with the new oral “blood thinner” Xarelto (Rivaroxaban), there are a few safety nets that your local hospital and physician may want to establish to make therapy as safe as possible for you. Issues to be addressed are (a) dosing, (b) management of major bleeding, (c) interruption of therapy for surgery, dental procedures, and other procedures, and d) what to do if you missed a dose.
These issues are probably best addressed by the establishment of a treatment algorithm/guide for the entire hospital or physician practice.Here is, as an example, what our institution, the University of North Carolina (UNC) Health Care System, has established. Your physicians and pharmacists are welcome to take this document and use it as a clinical reference for management issues, or modify it to fit their practice. A discussion of Xarelto for the use in the treatment of DVT and PE can be found on this Clot Connect blog.
Support Forum: Questions or comments about Xarelo and its use? Go to the online Clot Connect Support Forum, category “Anticoagulant Use (Blood Thinners)”.
Disclosure: I have consulted for Janssen Pharmaceuticals.
Last updated: Jan 11th, 2013